Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characteristics and trends of globally registered glioma clinical trials in the past 16 years. | Ther Adv Neurol Disord | 2022 | 35923217 | PubTator, text mining | PubMed |
| The multifaceted mechanisms of malignant glioblastoma progression and clinical implications. | Cancer Metastasis Rev | 2022 | 35920986 | PubTator, text mining | PubMed |
| Combination of genetically engineered T cells and immune checkpoint blockade for the treatment of cancer. | Immunother Adv | 2022 | 35919489 | PubTator, text mining | PubMed |
| Interleukin-13 increases the stemness of limbal epithelial stem cells cultures. | PLoS One | 2022 | 35917378 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities. | Front Immunol | 2022 | 35911706 | PubTator, text mining | PubMed |
| Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors. | Front Immunol | 2022 | 35903099 | PubTator, text mining | PubMed |
| CEBPD modulates the airway smooth muscle transcriptomic response to glucocorticoids. | Respir Res | 2022 | 35902923 | PubTator, text mining | PubMed |
| Prognostic signature for hepatocellular carcinoma based on 4 pyroptosis-related genes. | BMC Med Genomics | 2022 | 35902905 | PubTator, text mining | PubMed |
| Site-Specific Considerations on Engineered T Cells for Malignant Gliomas. | Biomedicines | 2022 | 35885047 | PubTator, text mining | PubMed |
| Sex-biased adaptive immune regulation in cancer development and therapy. | iScience | 2022 | 35880048 | PubTator, text mining | PubMed |
| Multivalent, Bispecific αB7-H3-αCD3 Chemically Self-Assembled Nanorings Direct Potent T Cell Responses against Medulloblastoma. | ACS Nano | 2022 | 35876221 | PubTator, text mining | PubMed |
| Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions. | Front Immunol | 2022 | 35874698 | PubTator, text mining | PubMed |
| From Anti-HER-2 to Anti-HER-2-CAR-T Cells: An Evolutionary Immunotherapy Approach for Gastric Cancer. | J Inflamm Res | 2022 | 35873388 | PubTator, text mining | PubMed |
| Locoregional infusion of IL13Rα2-specific immunotoxins in children and adults with high-grade glioma. | Ther Deliv | 2022 | 35872639 | PubTator, text mining | PubMed |
| The impact of biological sex on diseases of the urinary tract. | Mucosal Immunol | 2022 | 35869147 | PubTator, text mining | PubMed |
| Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy. | Cell Rep | 2022 | 35858579 | PubTator, text mining | PubMed |
| Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma. | Curr Opin Oncol | 2022 | 35855503 | PubTator, text mining | PubMed |
| Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS). | Clin Transl Allergy | 2022 | 35846226 | PubTator, text mining | PubMed |
| CAR T cell therapy in solid tumors: A review of current clinical trials. | EJHaem | 2022 | 35844304 | PubTator, text mining | PubMed |
| Genetic and hormonal mechanisms underlying sex-specific immune responses in tuberculosis. | Trends Immunol | 2022 | 35842266 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=36